Jobs

SepSight Diagnostics was incorporated in February 2019 by Ploughshare Innovations to commercialise a Protein biomarker assay for the early detection of sepsis. They now need to appoint a CEO designate to complete the information memorandum and raise seed funds for assay and prototype design activities. This initial phase of development will take the technology up to the pre-clinical validation inflection point.

ExecMind is a Life Science Executive Search company focused on recruitment of top scientists and management in global biotech and medtech industries.


Computational Chemist/Biophysicist

Location: Poland


Together with innovative biotech company, we are looking for an experienced scientist with strong technical and problem-solving skills in the field of Computational Chemistry/Biophysics.

The successful candidate will be responsible for Structure-Based Drug Design (SBDD), supporting hit expansion, hit-to-lead, lead optimization and molecular docking.

ExecMind is a Life Science Executive Search company focused on recruitment of top scientists and management in global biotech and medtech industries.


Senior Scientist in Cell Biology


Location: Poland


We are working with an ambitious biotech startup company, developing novel and innovative therapies, using an unique drug discovery approach. They are building key scientific staff, bringing in scientists and building international teams.

ExecMind is a Life Science Executive Search company focused on recruitment of top scientists and management in global biotech and medtech industries.


Principal Investigator – Immuno-oncology

Location: Poland

Isomerase is an innovative, growing biotechnology company based at Chesterford Research Park near Cambridge, UK. It was founded in 2012 and has particular expertise in synthetic biology, bioengineering and the discovery and development of the next generation of microbial natural products and peptides.

STORM Therapeutics is a University of Cambridge spin-out, translating the ground-breaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in oncology and other diseases. It is the leading company currently tackling disease through modulating RNA modifying enzymes and is developing a unique platform to address these enzyme classes, including RNA methyltransferases. Storm has established a pipeline of novel projects, and is looking to take projects to the clinic.

Isomerase is an innovative, growing biotechnology company based at Chesterford Research Park near Cambridge, UK. It was founded in 2012 and has particular expertise in synthetic biology, bioengineering and the discovery and development of the next generation of microbial natural products and peptides.

Our client is successfully expanding into the bioprocessing market and is now seeking a sales person to focus on our Biotechnology portfolio in Europe, focusing particularly on Research and Development laboratories in both industry and academia.


We are Ideally seeking individuals already working in or with Bio research companies in a sales capacity but we will consider scientists with a knowledge of the applications and market looking to move into a commercial role.

Our client is a highly successful business with a track record making biology and chemistry labs safer and more effective.

Business Development Executive - Spin-out


Salary: £50k-70k


Location: London, flexible working requests will be considered


Please note that there is no closing date for this role. Please do not delay your application to avoid disappointment.


The Commercial Partnerships team (CP) is dedicated to the development and commercialisation of innovative research. The team accelerates the translation of new ideas into treatments by bringing together the expertise, capabilities, and resources of CRUK and its academic network with that of industry partners.

Pages